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Crawling with Virus: Translational Insights from a Neonatal Mouse
Model on the Pathogenesis of Respiratory Syncytial Virus in Infants
Dahui You,a,b Jordy Saravia,a,b David Siefker,a,b Bishwas Shrestha,a,b Stephania A. Cormiera,b
Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, Tennessee, USAa; Children’s Foundation Research Institute at Le Bonheur Children’s
Hospital, Memphis, Tennessee, USAb
The infant immune response to respiratory syncytial virus (RSV) remains incompletely understood. Here we review the use of a
neonatal mouse model of RSV infection to mimic severe infection in human infants. We describe numerous age-specific re-
sponses, organized by cell type, observed in RSV-infected neonatal mice and draw comparisons (when possible) to human
infants.
Respiratory syncytial virus (RSV) is the most common cause oflower respiratory tract infections in infants, and severe RSV
disease during infancy is associated with an increased risk of
asthma development. The medical and economic burdens of RSV
infection are enormous. In the United States alone, there are
85,000 to 144,000 annual hospitalizations with $2.6 billion in as-
sociated estimated medical cost (1). Despite its continued impact
on global health, RSV remains without a vaccine or adequate ther-
apeutic.
While prematurity, immunodeficiency, and congenital heart
or chronic lung diseases are risk factors for severe RSV disease, the
majority of the infants requiring hospitalization were previously
healthy and less than 6 months of age (2), suggesting that age at the
time of initial infection is an important predictive factor for dis-
ease severity. Therefore, our grasp of severe RSV disease in infants
is inevitably tied to our understanding of developmental immu-
nity during the first year of life.
The neonatal mouse model of RSV infection has been an in-
valuable tool for RSV research (3, 4). Briefly, neonatal mice (7
days of age) are infected with RSV and then reinfected 4 weeks
later as adults. Compared to mice initially infected as adults, these
mice develop the characteristic Th2-biased immunopathologies,
including exaggerated pulmonary Th2 cells/cytokines, eosino-
philia, mucus hyperproduction, and airway hyperreactivity. In re-
cent years, this model spurred several significant advances in re-
search on how age-dependent differences in various immune and
nonimmune cells initiate the immunopathogenesis of RSV infec-
tion in infants. This article will briefly discuss said advances, or-
ganized by the cell types involved in responding to RSV.
EPITHELIAL CELLS
The major cellular target of RSV is airway epithelial cells. In the
lower respiratory tract, RSV infects bronchiolar and alveolar (type
I and II) epithelial cells (5) and similar cells in mice (6). During
infection, the airway epithelium is a major source of the “alarmin”
cytokine interleukin-33 (IL-33). Intriguingly, nasal aspirates from
infants with severe RSV disease have elevated levels of IL-33 (7, 8),
and variants of the IL-33 receptor gene IL1RL1 are associated with
severe RSV disease in human infants (9). Immediately following
RSV infection in neonatal mice, a robust IL-33 response is elicited
in CD45 EpCam pneumocytes (7); this type of response to RSV
infection does not occur in adult mice, suggesting age-dependent
regulation of IL-33 expression in the lung. Furthermore, the se-
verity of RSV infection (i.e., Th2-mediated immunopathology) is
dependent on the levels of IL-33 early during infection.
ILC2S
More recent work has provided a role for a previously unexplored
area of RSV immunology, group 2 innate lymphoid cells (ILC2s).
The receptor of IL-33, ST2, is highly expressed on ILC2s, in addi-
tion to Th2 cells, dendritic cells (DCs), eosinophils, and mast cells
(10). In addition to strongly promoting Th2 differentiation, IL-33
stimulates ILC2s to produce high levels of IL-13, leading to ele-
vated mucus production and airway dysfunction. Furthermore,
IL-33 and ILC2s are required for the immunopathophysiology
typically observed in allergic asthma, a disease phenotypically sim-
ilar to severe RSV in human infants. Interestingly, neonatal mice
have higher percentages of pulmonary ILC2s than adult mice do
(7). These data demonstrate a mechanistic role for epithelium-
derived IL-33 in RSV immunopathogenesis and suggest that IL-
33-mediated ILC2 responses are significant drivers of the Th2 im-
mune response.
DENDRITIC CELLS
Dendritic cells are the major antigen-presenting cells of the lungs
that orchestrate the adaptive immune response to RSV. Interest-
ingly, neonatal DCs (specifically, CD11b myeloid DCs [mDCs])
express higher levels of IL-4R (unpublished data) and IL-13R1
(11) than adult mDCs do. This increased IL-4R expression is
associated with a “less mature” phenotype of neonatal CD11b
mDCs, as evidenced by reduced expression of the costimulatory
molecules CD80 and CD86.
In addition to IL-4R and IL-13R1, OX40L is expressed on
pulmonary CD11b mDCs in an age-dependent manner (12).
The interaction between OX40L (expressed on antigen-present-
ing cells) and its receptor, OX40 (expressed on CD4 T cells), is
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important for Th2 cell activation and survival and therefore is
critical in inducing asthmatic responses in animal models. Neo-
natal mDCs express more OX40L than their adult counterparts
do, and its expression is further induced by RSV infection. When
neonatal mice are treated with antibodies against OX40L prior to
primary infection, the Th2-biased immunopathologies are also
diminished upon reinfection (12).
CD4 T CELLS
In addition to the increased expression of IL-4R on neonatal
DCs, the expression of IL-4R on CD4 T cells is higher in neo-
natal mice than in adult mice. Similar age-dependent IL-4R ex-
pression is observed in human infant and adult CD4 T cells,
which further increases in response to RSV stimulation (13). The
exact effect of elevated IL-4R levels on CD4 T cells in the infant
is unclear, but in mice, increased IL-4R expression is associated
with enhanced proliferation of Th2 cells, resulting a Th2-biased
responses during RSV reinfection (4). Further, the absence of IL-
4R specifically on CD4 T cells substantially decreases Th2-bi-
ased immunopathologies upon RSV reinfection (13).
OTHER CELLS THAT MAY PLAY A ROLE IN RSV
PATHOGENESIS OR PROTECTION
In addition to age-dependent factors that appear to drive Th2-
biased immunopathogenesis during RSV infection, other cells and
factors specific to infants are likely influencing disease severity. In
human infants, RSV severity is associated with increased viral
loads in nasal aspirates (14), and plasmacytoid dendritic cells
(pDCs) from cord blood mononuclear cells (CBMCs) are less able
to induce antiviral type I interferons (IFNs) than pDCs from adult
human PBMCs are (15). Consistent with human data, neonatal
mice are incapable of inducing a robust type I IFN and pDC re-
sponse in the lung (16).
The importance of IL17A-expressing gamma delta () T cells
in protecting against neonatal RSV infection has also been dem-
onstrated (17). Neonatal mice do not produce IL-17A during the
early responses to RSV, though they have more lung  T cells
than adult mice do. This deficit is attributed, in part, to impaired
inflammasome activation in neonatal mice, which mirrors data
from human studies using  T cells from CBMCs compared to
those from adult PBMCs.
CD8 T cells have also been shown to be critical in both RSV
clearance and pathogenesis. In fact, neonatal CD8 T cells re-
spond to RSV infection with an epitope hierarchy significantly
different from that of adult CD8 T cells (18). This difference is
due mainly to the immaturity of neonatal CD103 mDCs (i.e., less
expression of CD80 and CD86) (19).
THE OVERALL MODEL AND FUTURE STUDIES
On the basis of all of the existing data, we propose an overall model
of how age influences the nonimmune and immune cellular re-
sponses to RSV to induce Th2-biased immunopathologies (Fig.
1). In this model, RSV infects airway epithelial cells and induces
IL-33. IL-33 binds to ILC2s and induces IL-13. IL-13 then
activates and polarizes DCs to induce a Th2-biased response. Al-
ternatively, IL-33 can bind to DCs directly and increases the ex-
pression of OX40L, thereby inducing Th2 polarization via OX40-
OX40L interaction with Th cells. At each step, there is a
developmental check point resulting in the Th2 bias. Neonatal,
but not adult, epithelial cells produce excessive IL-33 in response
to RSV infection; ILC2s are present in greater amounts in neonatal
lungs and are capable of producing more IL-13 than adult ILC2s
do, resulting in a larger amount of IL-13 produced in response to
RSV infection. Neonatal DCs express more IL-4R (one IL-13
receptor component) than adult DCs do. Elevated IL-13 induc-
tion early during RSV infection suppresses CD11b mDC mat-
uration, which favors Th2 development. Further, neonatal Th2
cells express more IL-4R during RSV infection than their
adult counterparts do, and elevated IL-13 enhances their pro-
liferation. All of these factors act in concert and result in Th2-
biased immunopathogenesis in neonates but not in adults.
How are these factors developmentally regulated? Why do only
a portion of young infants develop severe disease during RSV
infection? Does any genetic or environmental component in-
fluence these aforementioned factors? Can therapeutics or pe-
diatric vaccines be developed by using these factors as targets?
The answers to all of these questions are unclear and warrant
further investigations.
FIG 1 RSV infection in neonatal mice. Airway epithelial cells (AEC) infected
with RSV produce high levels of IL-33, which signals through its receptor ST2
on ILC2s, resulting in increased ILC2 numbers and enhanced production of
IL-13. Neonatal DCs express more IL-4R, IL-13R1, and ST2 than adult DCs
do. Signaling through the IL-4R–IL-13R1 receptor complex is associated
with an enhanced ability of DCs to polarize Th2 responses. Epithelium-de-
rived IL-33, on the other hand, is believed to cause OX40L upregulation on
DCs, further enhancing their Th2-polarizing ability and exacerbating RSV
immunopathogenesis. This paradigm distinctly occurs in neonatal, but not
adult, mice. LN, lymph node.
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